1. Home
  2. EMBJ vs NBIX Comparison

EMBJ vs NBIX Comparison

Compare EMBJ & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Embraer S.A.

EMBJ

Embraer S.A.

HOLD

Current Price

$64.11

Market Cap

11.3B

Sector

Industrials

ML Signal

HOLD

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$174.26

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EMBJ
NBIX
Founded
1969
1992
Country
Brazil
United States
Employees
25037
N/A
Industry
Aerospace
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.3B
13.2B
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
EMBJ
NBIX
Price
$64.11
$174.26
Analyst Decision
Buy
Strong Buy
Analyst Count
1
22
Target Price
$84.00
$180.91
AVG Volume (30 Days)
1.2M
1.1M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
0.35%
N/A
EPS Growth
N/A
41.95
EPS
N/A
1.91
Revenue
N/A
$161,626,000.00
Revenue This Year
N/A
$24.73
Revenue Next Year
$13.60
$13.14
P/E Ratio
$159.30
$91.20
Revenue Growth
N/A
977.51
52 Week Low
$53.56
$122.14
52 Week High
$80.75
$174.38

Technical Indicators

Market Signals
Indicator
EMBJ
NBIX
Relative Strength Index (RSI) 61.28 68.22
Support Level $60.48 $153.96
Resistance Level $65.81 N/A
Average True Range (ATR) 1.78 4.45
MACD 0.54 0.52
Stochastic Oscillator 92.45 99.37

Price Performance

Historical Comparison
EMBJ
NBIX

About EMBJ Embraer S.A.

Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment. Geographically, the company operates in Brazil, Europe, Asia Pacific, North America, and Others.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: